Latest News on private equities market

China factory production key as Tesla reports third-quarter results

Tesla Inc is conducting trial production runs at its new $2 billion China factory for the past several weeks and will sell some of the first cars from the plant to its employees, sources told Reuters.



6 years ago

China's premier says cooperation with the U.S. can create mutual benefit

China's premier Li Keqiang says cooperation between China and the United States can create mutual benefit, as negotiations between the world's two largest economies over a trade war continue to drag on.



6 years ago

Global shares hit by tech problems and Brexit snags

World stock markets fell on Wednesday, as hopes faded that a Brexit deal would be wrapped by next week and a profit warning from Texas Instruments pulled down tech shares.



6 years ago

Huawei launches foldable phone in China at prices starting from $2,400

Huawei Technologies Co Ltd started taking orders on Wednesday in China for its eagerly awaited foldable smartphone, as it ramps up marketing at home to make up for weak overseas sales amid U.S. trade sanctions.



6 years ago

Samsung updates software to fix fingerprint recognition problem

Samsung Electronics Co Ltd has updated software to fix problems with fingerprint recognition features on its flagship Galaxy S10 and Note 10 smartphones, it said on Wednesday.



6 years ago

Caterpillar profit falls 13.5%; cuts 2019 profit outlook

Caterpillar Inc reported a 13.5% fall in quarterly profit on Wednesday, hit by weak demand in its construction and resources units, and the company cut its 2019 profit forecast.



6 years ago

Zuckerberg faces grilling on Facebook's ambitious digital currency plans

Facebook Inc chief executive Mark Zuckerberg will be grilled by lawmakers over the company's plan to launch a digital currency and efforts to prevent foreign election interference when he appears before a Congressional panel on Wednesday.



6 years ago

Eli Lilly reports 9% rise in third-quarter profit

Eli Lilly and Co reported a 9.1% increase in third-quarter profit on Wednesday, helped by higher sales of its top-selling diabetes drug, Trulicity, and lower tax expense.



6 years ago

Health insurer Anthem profit beats, raises 2019 earnings forecast

Anthem Inc reported a better-than-expected quarterly profit on Wednesday as it benefited from higher sales of its government-backed health plans, prompting the health insurer to raise its full-year profit forecast.



6 years ago

Brewer Heineken tempers profit hopes as Americas slip

Heineken , the world's second-largest brewer, forecast profit this year would be at the bottom end of its previous guidance after an unexpected dip in third-quarter sales in the Americas partly offset strong growth in Asia.



6 years ago

SoftBank adds to financial burden with $10 billion WeWork deal

SoftBank Group Corp's financial strains escalated on Wednesday as it agreed to spend more than $10 billion to take over office-space sharing startup WeWork, knocking the Japanese tech conglomerate's already weakened shares.



6 years ago

Boeing profit slumps 53% as MAX grounding takes heavy toll

Boeing Co reported a 53% drop in quarterly profit on Wednesday, as the world's largest planemaker was hurt by the grounding of its best-selling 737 MAX jets.



6 years ago

Shares sapped by tech problems and Brexit snags

World stock markets struggled on Wednesday, as hopes faded that a Brexit deal would be wrapped by next week and a profit warning from Texas Instruments pulled down technology shares.



6 years ago

Blackstone reports better-than-expected third-quarter earnings

Blackstone Group Inc , the world's largest manager of alternative assets such as private equity and real estate, said on Wednesday that its distributable earnings in the third quarter fell 8% year-on-year, surpassing most analyst estimates.



6 years ago

Eli Lilly misses sales estimates as top-seller Trulicity disappoints

Eli Lilly and Co's quarterly sales missed Wall Street estimates on Wednesday due to a weaker-than-expected performance of its diabetes drug Trulicity because of lower realized prices, sending shares down 3%.



6 years ago